FORT COLLINS, Colo. (KDVR) – Colorado State University (CSU) has research teams working on four coronavirus vaccine development projects:
- Using an engineered bacterium
- A combination of light and vitamin B2
- A modified poxvirus used against smallpox
- A tuberculosis vaccine platform
Mary Jackson, a professor in the Department of Microbiology, Immunology and Pathology at Colorado State University, is leading a new research project investigating a tuberculosis vaccine platform to determine if it could be effective in fighting COVID-19.
The platform, Bacillus Calmette-Guerin (BCG), is a widely used vaccine used to prevent tuberculosis worldwide.
“Countries that practice universal BCG vaccination seem to have fewer cases of COVID-19 and a lower mortality rate,” said Jackson in an interview with CSU’s news platform SOURCE.
“In general, it seems that the vaccine somehow prepares the immune system to better protect people of all ages from a broad range of diseases caused by bacteria, fungi or viruses.”